Table 1. Comparison of baseline parameters between control and BPH patients.
Variable | Control (n=22) | BPH (n=45) | p-value |
---|---|---|---|
Age (y) | 64.2±5.5 | 66.1±8.2 | 0.48 |
PSA (ng/dL) | 1.5±0.6 | 5.7±7.4 | 0.06 |
Serum hormone concentration | |||
Estradiol (pg/dL) | 22.4±8.8 | 27.9±11.1 | 0.13 |
Testosterone (ng/dL) | 394.8±193.8 | 350.6±129.0 | 0.37 |
Estradiol/testosterone ratio | 0.08±0.07 | 0.1±0.05 | 0.25 |
Prostate size (g) | 19.4±4.8 | 46.1±15.5 | <0.001 |
Baseline urine flow | |||
PVR (mL) | 10.5±15.5 | 121.0±113.6 | 0.004 |
Qmax (mL/s) | 15.9±3.9 | 7.7±3.3 | <0.001 |
Values are presented as mean±standard deviation.
BPH, benign prostatic hyperplasia; PSA, prostate-specific antigen; Qmax, maximal flow rate.